Abstract:
Described herein are compositions and methods for the prognosis of mesothelioma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for prognosis of malignant lymphoma. The compositions are microRNA molecules associated with the prognosis of lymphoma, as well as various nucleic acid molecules relating thereto or derived thereof.
Abstract:
Described herein are compositions and methods for the prognosis of renal cancer patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of renal cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the prognosis of melanoma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the diagnosis and treatment of mesothelioma patients and the prognosis of mesothelioma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with diagnosis, treatment and prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma or with melanoma brain tropism, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the prognosis of renal cancer patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of renal cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the prognosis of melanoma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with the prognosis of melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for the prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma or with melanoma brain tropism, as well as various nucleic acid molecules relating thereto or derived therefrom.
Abstract:
Described herein are compositions and methods for prognosis of malignant lymphoma. The compositions are microRNA molecules associated with the prognosis of lymphoma, as well as various nucleic acid molecules relating thereto or derived thereof.